MINNEAPOLIS--(BUSINESS WIRE)--Aug. 7, 2006--MGI PHARMA, INC. (Nasdaq:MOGN - News), a biopharmaceutical company focused in oncology and acute care, today announced the appointments of Mary Lynne Hedley, Ph.D., Eric P. Loukas, Esq., and William F. Spengler to Executive Vice President and the appointment of Mr. Loukas as Chief Operating Officer.
